ArticleNPJ precision oncology2024

Baseline biomarkers of efficacy and on-treatment immune-profile changes associated with bempegaldesleukin plus nivolumab.

Helen Gogas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.